Product Code: RP-ID-10352507 |
Published Date: 21 Mar 2025 |
Region: Global |
Category: Chemicals |
Report ID: 10352507
Market Overview:
Aptamers Market Analysis by type (DNA Aptamers, RNA Aptamers and XNA Aptamers); by Technology (SELEX, and Others); by Application (Therapeutics Development, Research & Development, Diagnostic, and Others); and by End User (Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes, CROs, and Others)-Global Supply & Demand Analysis & Opportunity Outlook 2023-2035
Global Aptamers Market Scope Report
|
Base Year |
2022 |
|
Forecast Year |
2023-2035 |
|
CAGR |
~24% |
|
Base Year Market Size (2022) |
~ USD 2 Billion |
|
Forecast Year Market Size (2035) |
~ USD 11 Billion |
Global Aptamers Market Highlights Over 2023 - 2035
The global aptamers market is estimated to garner a revenue of ~USD 11 billion by the end of 2035 by growing at a CAGR of ~24% over the forecast period, i.e., 2023 – 2035. Further, the market generated a revenue of ~USD 2 billion in the year 2022. The wide prevalence of non-communicable and age-related diseases worldwide is expected to contribute substantially to the growth of the global aptamers market in the forecast period. The yearly number of deaths before the age of 70 caused by non-communicable diseases all over the world is estimated to be close to 18 million people.
GET A SAMPLE COPY OF THIS REPORT
Similarly, the worldwide prevalence of age-related macular degeneration (AMD) is projected to reach ~290 million in 2040. Throughout the years, aptamers have been used successfully to recognize cancer and pathogens, monitor environmental pollution, and more. Hence the prevalence of various diseases is expected to create a vast demand for aptamers and thus, growth in the global aptamers market.
Global Aptamers Market: Growth Drivers and Challenges
Growth Drivers
-
Rapid Increase in Healthcare Spending to Combat New Diseases – It is estimated that the beginning of COVID-19 was followed by a significant increase in the healthcare sector’s spending as the expenditure from manufacturers of vaccines and drugs increased by a maximum of ~21%. The increase in expense with each new disease is inevitable, especially in the case of an outbreak. It can be observed that much of the spending goes to the research to study, control, prevent, and respond to reemerging and new infectious diseases.
-
Considerable Increase in Research and Development (R&D) Spending of Corporates – With considerable revenue growth, the Chinese e-commerce business Alibaba increased its budget for R&D by up to 33% in 2020.
-
Considerable Access to Diagnostic Facilities – As of 2022, the number of businesses that are diagnostic and medical laboratories in the United States (U.S.) is more than 24,800.
-
Steady Growth of Geriatric Population – The Americans aged 65 and above is projected to reach ~22% of the total population by 2040.
Challenges
-
Nuclease Resistance to Restrain the Growth of Therapeutic Aptamers
-
Greater Market Acceptance for Antibodies
-
Degradation Of Some Aptamers in Biomolecules, Making Them Unsuitable for Medical Applications
The global aptamers market is segmented and analyzed for demand and supply by application into therapeutics development, research & development, diagnostics, and others. The diagnostics segment among these is projected to hold a significant market share by the end of 2035 as a result of the rapid growth in diseases, the need for updated diagnostic kits, and the increasing investment toward the diagnosis and treatment of target diseases. According to the National Cancer Institute (NCI), the total funding available in FY (fiscal year) 2020 amounted to over USD 6 billion, which was a ~9% increase from the previous year. Targeting tumor markers, including tenascin, is a critical application of aptamers in cancer diagnosis.
Global Aptamers Market Regional Synopsis
Regionally, the global aptamers market is studied into five major regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. Amongst these markets, the market in the North American region is projected to hold the largest market share by the end of 2035. An extensive prevalence of target diseases in the area would keep aptamers in demand for both therapeutic and diagnostic applications, while robust healthcare facilities will result in the regional market holding the largest market share in the forecast period. For instance, it is estimated that every year in the US, more than 800,000 people experience a heart attack.
Market Segmentation
Our in-depth analysis of the global aptamers market includes the following segments:
|
By Type |
|
|
By Technology |
|
|
By Application |
|
|
By End User |
|
Key Companies Dominating the Global Aptamers Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global aptamers market that are included in our report are SomaLogic, Inc., Aptamer Group plc, Aptamer Sciences, Inc, Base Pair Biotechnologies, Inc., Vivonics Inc., Aptagen, LLC, TriLink BioTechnologies, Raptamer Discovery Group, NeoVentures Biotechnology Inc., APTUS BIOTECH S.L, and others.
Global Aptamers Market: Latest Developments
-
January, 2021: Raptamer Discovery Group announced being awarded the Small Business Administration Tibbetts Award for their showing significant social and economic impact from the funding for R&D.
-
April, 2020: TriLink BioTechnologies announced entering into an agreement with Imperial College London to produce self-amplifying RNA (saRNA) for the development of the COVID-19 vaccine.
Key Reasons to Buy Our Report
-
The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
-
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
-
The report includes detailed company profiles of the major players dominating the market.
-
We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
-
We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
- SomaLogic Inc.
- Aptamer Group plc
- Aptamer Sciences Inc
- Base Pair Biotechnologies Inc.
- Vivonics Inc.
- Aptagen LLC
- TriLink BioTechnologies
- Raptamer Discovery Group
- NeoVentures Biotechnology Inc.
- APTUS BIOTECH S.L
Related Reports
Proof of Quality & Reliability
